Compare Novartis AG (NVS) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Taskus Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Novartis AG is far larger — about 545.5× Taskus Inc's market cap, and Novartis AG pays a 3.17% dividend while Taskus Inc pays none. Which is the better fit depends on your goals.
| NVS | TASK | |
|---|---|---|
Market Cap | $290.25B | $532.07M |
Sector | Health | Technology |
52-Week High | $168.62 | $18.21 |
52-Week Low | $113.50 | $4.57 |
Enterprise Value | $330.27B | $927.77M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
